Zobrazeno 1 - 10
of 89
pro vyhledávání: '"Elisabeth P. Nacheva"'
Autor:
Colin Grace, Elisabeth P. Nacheva
Publikováno v:
Cancer Informatics, Vol 2012, Iss 11, Pp 173-183 (2012)
Externí odkaz:
https://doaj.org/article/e56f7a75044444c48a4191381baaebde
Autor:
Marc R. Mansour, Robertus A.M. de Bruin, David C. Linch, Javier Herrero, Stephen Henderson, Elisabeth P. Nacheva, Rajeev Gupta, José Afonso Guerra-Assunção, Sara Ahrabi, Simon E. Richardson, Nadine Farah, Brian Philip, Michael Magnussen, Sunniyat Rahman, Cosetta Bertoli, Tanya Rapoz-D'Silva, Theresa E. León
Loss-of-function mutations of EZH2, the enzymatic component of PRC2, have been associated with poor outcome and chemotherapy resistance in T-cell acute lymphoblastic leukemia (T-ALL). Using isogenic T-ALL cells, with and without CRISPR/Cas9–induced
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4089bdc0a61ebcf86d1dc460a116dd79
https://doi.org/10.1158/2159-8290.c.6547820.v1
https://doi.org/10.1158/2159-8290.c.6547820.v1
Autor:
Marc R. Mansour, Robertus A.M. de Bruin, David C. Linch, Javier Herrero, Stephen Henderson, Elisabeth P. Nacheva, Rajeev Gupta, José Afonso Guerra-Assunção, Sara Ahrabi, Simon E. Richardson, Nadine Farah, Brian Philip, Michael Magnussen, Sunniyat Rahman, Cosetta Bertoli, Tanya Rapoz-D'Silva, Theresa E. León
Supplementary Table 2: Cell viability data from the small-molecule drug screening in EZH2-WT and EZH2-KO1 cells (related to Fig. 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9e26a77353001cee6173af99ff4ca604
https://doi.org/10.1158/2159-8290.22535303
https://doi.org/10.1158/2159-8290.22535303
Autor:
Marc R. Mansour, Robertus A.M. de Bruin, David C. Linch, Javier Herrero, Stephen Henderson, Elisabeth P. Nacheva, Rajeev Gupta, José Afonso Guerra-Assunção, Sara Ahrabi, Simon E. Richardson, Nadine Farah, Brian Philip, Michael Magnussen, Sunniyat Rahman, Cosetta Bertoli, Tanya Rapoz-D'Silva, Theresa E. León
Supplementary Table 3: Mutations identified by exome sequencing in Liu et al., 2017 T-ALL cohort (related to Fig. 5G)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::25ea44d21ae7274a589b69661541a050
https://doi.org/10.1158/2159-8290.22535300.v1
https://doi.org/10.1158/2159-8290.22535300.v1
Autor:
Marc R. Mansour, Robertus A.M. de Bruin, David C. Linch, Javier Herrero, Stephen Henderson, Elisabeth P. Nacheva, Rajeev Gupta, José Afonso Guerra-Assunção, Sara Ahrabi, Simon E. Richardson, Nadine Farah, Brian Philip, Michael Magnussen, Sunniyat Rahman, Cosetta Bertoli, Tanya Rapoz-D'Silva, Theresa E. León
Supplementary Figures and Legends
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7bc9558b116cac1d0add91d3d2effc13
https://doi.org/10.1158/2159-8290.22535309.v1
https://doi.org/10.1158/2159-8290.22535309.v1
Autor:
Marc R. Mansour, Robertus A.M. de Bruin, David C. Linch, Javier Herrero, Stephen Henderson, Elisabeth P. Nacheva, Rajeev Gupta, José Afonso Guerra-Assunção, Sara Ahrabi, Simon E. Richardson, Nadine Farah, Brian Philip, Michael Magnussen, Sunniyat Rahman, Cosetta Bertoli, Tanya Rapoz-D'Silva, Theresa E. León
Supplementary Table 1: List of the main targets and number of probes included in the small-molecule inhibitors library (related to Fig. 1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8108d332308a794f810eccbc0945b3e9
https://doi.org/10.1158/2159-8290.22535306.v1
https://doi.org/10.1158/2159-8290.22535306.v1
Autor:
Marc R. Mansour, Robertus A.M. de Bruin, David C. Linch, Javier Herrero, Stephen Henderson, Elisabeth P. Nacheva, Rajeev Gupta, José Afonso Guerra-Assunção, Sara Ahrabi, Simon E. Richardson, Nadine Farah, Brian Philip, Michael Magnussen, Sunniyat Rahman, Cosetta Bertoli, Tanya Rapoz-D'Silva, Theresa E. León
Supplementary information provided in this work.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::061e33a369539445814d90ed1312c0eb
https://doi.org/10.1158/2159-8290.22535297.v1
https://doi.org/10.1158/2159-8290.22535297.v1
Autor:
Tomasz Skorski, Elisabeth P. Nacheva, Tomasz Stoklosa, Eliza Glodkowska-Mrowka, Yashodhara Dasgupta, Mateusz Koptyra, Anna Virgili
Supplementary Tables 1-2, Figures 1-2 from Imatinib Sensitivity in BCR-ABL1–Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a102de34845af24cb021ddf173a968fe
https://doi.org/10.1158/0008-5472.22388076.v1
https://doi.org/10.1158/0008-5472.22388076.v1
Autor:
Tomasz Skorski, Elisabeth P. Nacheva, Tomasz Stoklosa, Eliza Glodkowska-Mrowka, Yashodhara Dasgupta, Mateusz Koptyra, Anna Virgili
Supplementary Methods from Imatinib Sensitivity in BCR-ABL1–Positive Chronic Myeloid Leukemia Cells Is Regulated by the Remaining Normal ABL1 Allele
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::464a581818093fa514e12025b4fc024a
https://doi.org/10.1158/0008-5472.22388079
https://doi.org/10.1158/0008-5472.22388079
Autor:
Alex Bataller, Jordi Esteve, Patrice Chevallier, Nathalie Grardel, Mónica López-Guerra, Clara Bueno, Francesca Guijarro, Rolf Marschalek, Sílvia Beà, Aurélie Caye, Jen-Fen Fu, Temenuzhka Boneva, Pablo Menendez, Marion Strullu, Elisabeth P. Nacheva, Arthur Sterin, Claus Meyer, Laura Magnano, Patrizia Larghero, Lee-Yung Shih, Pablo Mozas, Jan Zuna, Oscar Molina, Marketa Zaliova, Pascale Cornillet-Lefebvre
Publikováno v:
Blood Advances